Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells

Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells

Enrique Pérez-Cárdenas,1 Lucía Taja-Chayeb,1 Catalina Trejo-Becerril,1 José Chanona-Vilchis,2 Alma Chávez-Blanco,1 Guadalupe Domínguez-Gómez,1 Elizabeth Langley,1 Alejandro García-Carrancá,3,4 Alfonso...

Full description

Bibliographic Details
Main Authors: Pérez-Cárdenas E, Taja-Chayeb L, Trejo-Becerril C, Chanona-Vilchis J, Chávez-Blanco A, Domínguez-Gómez G, Langley E, García-Carrancá A, Dueñas-González A
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:OncoTargets and Therapy
Subjects:
Hydralazine
valproic acid
epigenetics
metastasis
ras
Online Access:https://www.dovepress.com/antimetastatic-effect-of-epigenetic-drugs-hydralazine-and-valproic-aci-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/antimetastatic-effect-of-epigenetic-drugs-hydralazine-and-valproic-aci-peer-reviewed-article-OTT

Similar Items